In vivo PS-OCT to detect fibrotic lung disease

M. Vaselli (Amsterdam, Netherlands), K. Mooij - Kalverda (Amsterdam, Netherlands), P. Bonta (Amsterdam, Netherlands), J. De Boer (Amsterdam, Netherlands), J. Annema (Amsterdam, Netherlands)

Source: Virtual Congress 2021 – Novelties in interventional pulmonology
Session: Novelties in interventional pulmonology
Session type: Oral Presentation
Number: 234

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Vaselli (Amsterdam, Netherlands), K. Mooij - Kalverda (Amsterdam, Netherlands), P. Bonta (Amsterdam, Netherlands), J. De Boer (Amsterdam, Netherlands), J. Annema (Amsterdam, Netherlands). In vivo PS-OCT to detect fibrotic lung disease. 234

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
3he MRI and an animal model of interstitial lung disease
Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities
Year: 2009



The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 327s
Year: 2006

Case-based imaging of connective tissue disease-related lung disease
Source: Virtual Congress 2021 – Imaging grand round
Year: 2021


Biological- and imaging biomarkers of edema and fibrosis in a rat model of drug-induced interstitial lung disease (DIILD)
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019

Identifying serum molecular biomarkers that distinguish emphysema and early fibrotic interstitial lung disease.
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021


MRI and CT imaging of in vivo models of drug-induced interstitial lung diseases.
Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease
Year: 2018


Novel imaging biomarkers for assessment of lung fibrosis and inflammation
Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease
Year: 2021


A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases.
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021


Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease
Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease
Year: 2020




In vivo monitoring of cystic fibrosis-like lung disease in mice by volumetric computed tomography
Source: Eur Respir J 2011; 38: 1060-1070
Year: 2011



Quantitative assessment of lung pathology in interstitial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 243s
Year: 2001

Computed-tomography-based radiomics features for staging of interstitial lung disease – transferability from experimental to human lung fibrosis - a proof-of-concept study
Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Year: 2019

KL-6, SP-D and MMP-7 as serum biomarkers for early detection of interstitial lung diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Probe-based confocal laser-endomicroscopy imaging of differential auto-fluorescence of alveolar macrophages in diffuse lung diseases
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018

B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Pertechnegas lung clearance in different forms of interstitial lung disease
Source: Eur Respir J 2002; 19: 31-36
Year: 2002



Unravelling specific mechanisms of wound healing and pulmonary fibrosis in human ex vivo lung tissue slices
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018


MRI metric lung parenchyma T1 indicates lung pathology in patients with pulmonary hypertension.
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021


Siphonage lung disease
Source: Virtual Congress 2020 – Respiratory critical care
Year: 2020


Lung ultrasound in the evaluation of interstitial lung diseases in the course of connective tissue diseases
Source: International Congress 2017 – Rare diseases
Year: 2017